• Home
• About Us
• Research
• Clinical Programme
• Patient Info
• Cystic Fibrosis
• Gene Therapy
• Publications
• MFIA 2011

Medical Futures Innovation Awards 2011

The Consortium won two awards at the Medical Futures Innovation Awards 2011

MRC Translational Research Award & Best Therapeutic Innovation (Respiratory)

Viral Gene Therapy for Cystic Fibrosis Lung Disease

Members of the Consortium Strategy Group and guests at the awards.

The Consortium's Lentiviral Gene Therapy Programme was nominated in the respiratory category for the 2011 Medical Futures Innovation Awards.

The Consortium won two awards:

- Best Therapeutic Innovation in the Respiratory Innovation Awards
- Best Translational Research Innovation

Browse this section to learn more about our lentiviral vector work and the award.

Medical Futures Innovation Award for Best Translational Research Innovation.

Medical Futures Innovation Award for Best Therapeutic Innovation (Respiratory)

About the Medical Futures Awards

A Medical Futures Innovation Award is one of the UK's most sought after healthcare and business accolades, rewarding ground-breaking innovation from front line clinicians and scientists.

The reward recognises ideas that have the potential to transform peoples' lives and demonstrate the NHS and UK's position as a worldwide contender. The Awards cover a number of therapy areas from Cardiovascular Disease to Respiratory Disease. A unique element of these Awards is the unparalleled peer review and credibility that is brought to exciting early stage innovation and technologies.

They are judged by a panel of the most distinguished doctors and business leaders in the country. Experts such as Sir Bruce Keogh, Medical Director for the NHS; and Business Icon, Sir Anthony Jolliffe, come together as Europe's leading think-tank on healthcare innovation.